Why healthcare innovation can't wait for politics
Listen now
Description
Ash Zenooz and Luba Greenwood interview Andrea Ippolito about her extensive career in healthcare spanning academia, government, and the private sector, as well as her current role as founder and CEO of SimpliFed. They discuss the intricacies of government roles, the importance of women's health, and the evolving landscape of maternal health care and entrepreneurship. For full show notes, visit: https://highlightai.com/share/2c96255c-b8e5-4469-855f-dc5c22f6a339 — 📰 Be notified early when Turpentine drops new publication: https://www.turpentine.co/exclusiveaccess  🙏 Help shape our show by taking our quick listener survey at https://bit.ly/TurpentinePulse  — LINKS:  SimpliFed: https://www.simplifed.com/ Subscribe to Second Opinion Newsletter: https://secondopinion.media/  — FOLLOW: https://www.linkedin.com/in/andreakippolito  https://www.linkedin.com/in/christinafarr/ https://www.linkedin.com/in/lubagreenwood/ https://www.linkedin.com/in/ashzenooz/ — TIMESTAMPS: (00:00) Intro (02:04) Andrea's government experience (02:41) Impact of political transitions (03:25) Challenges and opportunities in women's health (10:52) SimpliFed: A journey in women's health (14:12) Scaling SimpliFed (16:43) Fundraising in women's health (20:55) The future of women's health (23:09) Impact of abortion regulations on valuations (23:56) Trends in fertility and IVF (24:22) High-risk conditions in maternal health (25:14) Veterans' healthcare benefits (26:20) Advocating for change through Congress (29:53) Drug pricing and international policies (39:37) Encouraging innovation in women's health (41:11) The Debrief
More Episodes
Luba Greenwood and Ash Zenooz discuss the evolving biotech landscape, the impact of AI on drug discovery, the importance of using real-world evidence in drug development, and personal motivations for continuing efforts in the biotech field. For full show notes, visit:...
Published 11/20/24
Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Zeke Emanuel, a prominent oncologist, bioethicist, and influential voice in healthcare to discuss the impact of GLP-1 drugs, healthcare affordability, Trump's appointments, and AI in medicine. The second half of the episode was recorded...
Published 11/16/24